Cardinal Health in the news

Cardinal Health's OptiFreight® Logistics focuses on leveraging real-time visibility and data analytics to optimize the healthcare supply chain, ensuring critical medical products reach patients efficiently and accurately.

CVS Health prolonged its pharmaceutical distribution deals with Cardinal Health and McKesson until 2032, securing its drug supply for nationwide pharmacy and retail operations.

Cardinal Health extends its distribution agreement with CVS Health until 2032 and reaffirms its fiscal 2027 earnings guidance.

The NCPA Foundation secured grants from Cardinal Health Foundation and Truist Foundation to support disaster relief for independent pharmacies and a program for rural pharmacy ownership.

Cardinal Health extended its pharmaceutical distribution agreement with CVS Health through June 30, 2032, and reaffirmed its fiscal year 2027 and long-term EPS guidance.

Cardinal Health demonstrates its robust and adaptable supply chain, successfully navigating various natural disasters and emergencies to ensure healthcare providers consistently receive essential medical products.

Cardinal Health is back on the market's radar due to its pharmaceutical distribution and specialty growth, driven by demand for specialty drugs and supported by operational efficiency and disciplined capital management, despite challenges like customer concentration and litigation.

Cardinal Health highlights its robust supply chain's ability to maintain medical product access for healthcare providers during emergencies like natural disasters, wildfires, and facility disruptions.

Cardinal Health Inc. stock surpassed its competitors due to strong trading.

Cardinal Health and CVS Health extended their distribution agreement until 2032, offering CVS better logistics visibility and supporting its integrated business model and dividend commitment.

Cardinal Health's stock outperformed the broader market, and its upcoming earnings report is highly anticipated by investors.

Cardinal Health extended its pharmaceutical distribution deal with CVS Health until 2032, maintaining service scope and reaffirming 2027 EPS growth guidance, which supports its long-term strategy for higher-value services.

CVS Health extended its distribution deal with Cardinal Health through fiscal year 2032, maintaining its status as Cardinal's largest customer.

Cardinal Health and McKesson extended their distribution contracts with CVS until 2032, maintaining service scope and reaffirming financial guidance for Cardinal Health, despite significant customer concentration risks.

The Medical-Dental Supplies industry is benefiting from healthcare shifts and technology adoption, with a projected 10% CAGR to $318.77 billion by 2031, despite ongoing challenges like inflation.

Cardinal Health and McKesson extended their pharmaceutical distribution partnerships with CVS Health, leading to reaffirmed earnings guidance for both companies.

Cardinal Health will continue its pharmaceutical distribution agreement with CVS Health until mid-2032 and reaffirmed its earnings growth guidance.

Cardinal Health will announce its first-quarter fiscal year 2027 financial results on November 5.

Cardinal Health renewed its distribution services agreement with CVS Health, and reaffirmed its financial targets.